216 related articles for article (PubMed ID: 18369971)
1. Extended-release oral drug delivery technologies: monolithic matrix systems.
Tiwari SB; Rajabi-Siahboomi AR
Methods Mol Biol; 2008; 437():217-43. PubMed ID: 18369971
[TBL] [Abstract][Full Text] [Related]
2. Critical factors in the release of drugs from sustained release hydrophilic matrices.
Maderuelo C; Zarzuelo A; Lanao JM
J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
4. The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion.
Lyons JG; Devine DM; Kennedy JE; Geever LM; O'Sullivan P; Higginbotham CL
Eur J Pharm Biopharm; 2006 Aug; 64(1):75-81. PubMed ID: 16697170
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid excipients - matrix agents for sustained drug delivery.
Rosiaux Y; Jannin V; Hughes S; Marchaud D
J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
[TBL] [Abstract][Full Text] [Related]
6. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
[TBL] [Abstract][Full Text] [Related]
7. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
Kumar P; Singh S; Mishra B
Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
[TBL] [Abstract][Full Text] [Related]
8. Sustained delivery of captopril from floating matrix tablets.
Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
[TBL] [Abstract][Full Text] [Related]
9. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
Asghar LF; Azeemuddin M; Jain V; Chandran S
Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981
[TBL] [Abstract][Full Text] [Related]
10. Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices.
Veiga F; Salsa T; Pina ME
Drug Dev Ind Pharm; 1998 Jan; 24(1):1-9. PubMed ID: 15605591
[TBL] [Abstract][Full Text] [Related]
11. Micro-CT in drug delivery.
Wang Y; Wertheim DF; Jones AS; Coombes AG
Eur J Pharm Biopharm; 2010 Jan; 74(1):41-9. PubMed ID: 19465120
[TBL] [Abstract][Full Text] [Related]
12. Silk fibroin as a vehicle for drug delivery applications.
Wenk E; Merkle HP; Meinel L
J Control Release; 2011 Mar; 150(2):128-41. PubMed ID: 21059377
[TBL] [Abstract][Full Text] [Related]
13. Oral pulsatile delivery systems based on swellable hydrophilic polymers.
Gazzaniga A; Palugan L; Foppoli A; Sangalli ME
Eur J Pharm Biopharm; 2008 Jan; 68(1):11-8. PubMed ID: 17888641
[TBL] [Abstract][Full Text] [Related]
14. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
16. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
[TBL] [Abstract][Full Text] [Related]
17. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
Mittal A; Sara US; Ali A; Mohammed A
Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo simulations for the study of drug release from cylindrical matrix systems with an inert nucleus.
Martínez L; Villalobos R; Sánchez M; Cruz J; Ganem A; Melgoza LM
Int J Pharm; 2009 Mar; 369(1-2):38-46. PubMed ID: 19027839
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins: application in different routes of drug administration.
Shimpi S; Chauhan B; Shimpi P
Acta Pharm; 2005 Jun; 55(2):139-56. PubMed ID: 16179128
[TBL] [Abstract][Full Text] [Related]
20. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process.
Lyons JG; Hallinan M; Kennedy JE; Devine DM; Geever LM; Blackie P; Higginbotham CL
Int J Pharm; 2007 Feb; 329(1-2):62-71. PubMed ID: 17010544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
